Education
About Us
Working with TipRanks
Follow Us
Astellas Pharma Inc (ALPMF)
OTHER OTC:ALPMF
Earnings Data
Report Date
Jul 30, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
0.13Last Year’s EPS
0.14Same Quarter Last Year
Moderate Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Apr 25, 2025
|% Change Since: 5.07%
|Next Earnings Date:Jul 30, 2025
Earnings Call Sentiment|Positive
Astellas Pharma demonstrated strong financial performance with record-breaking revenue and significant growth in Strategic Brands. Successful cost optimization and a positive outlook for FY 2025, including increased dividends and progress in primary focus programs, highlight a positive trajectory. Despite challenges such as the impact of U.S. Medicare Part D redesign and temporary demand issues with IZERVAY, the overall sentiment remains optimistic.Company Guidance
During the FY 2024 financial results announcement by Astellas Pharma Inc., several key financial metrics were highlighted, indicating a record year for the company. Revenue reached ¥1.912 trillion, marking a 19.2% increase year-on-year, while core operating profit rose by 41.7% to ¥392.4 billion. The company achieved significant growth in its Strategic Brands, with sales exceeding ¥340 billion, reflecting a growth of ¥180 billion or 110% year-on-year. The core operating profit margin improved by 3.3 percentage points to 20.5%. Astellas also reported substantial cost optimization, achieving a target of ¥40 billion, which improved the SG&A ratio by 3.1 percentage points. The Forex impact positively contributed ¥68.1 billion to revenue and ¥15.1 billion to core operating profit. Looking forward, Astellas forecasts further growth in FY 2025, with expected revenue of ¥1.930 trillion and a core operating profit increase to ¥410 billion, driven by continued expansion in Strategic Brands and ongoing cost optimization efforts.Record-Breaking Revenue and Growth
In FY 2024, Astellas Pharma reported record high revenue of ¥1.912 trillion, a 19.2% increase year-on-year, and core operating profit of ¥392.4 billion, up by 41.7% year-on-year.
Strategic Brands Driving Growth
Sales of Strategic Brands, including PADCEV, IZERVAY, VEOZAH, VYLOY, and XOSPATA, exceeded ¥340 billion, more than doubling with a growth of ¥180 billion or 110% year-on-year.
Cost Optimization Success
Astellas Pharma achieved its cost optimization target of ¥40 billion in FY 2024, improving the SG&A ratio by 3.1 percentage points year-on-year.
Strong Outlook for FY 2025
Astellas expects continued strong momentum in Strategic Brands with projected revenue of ¥1.930 trillion and underlying growth excluding Forex impact expected to be 7%.
Dividend Increase
Astellas increased its dividend per share to ¥78, an increase of ¥4, in anticipation of future profit growth.
Primary Focus Program Progress
ASB-3082 achieved proof of concept (PoC) in pancreatic ductal adenocarcinoma, marking a significant milestone in targeted protein degradation.
---
ALPMF Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ALPMF Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Apr 25, 2025 | $8.87 | $10.12 | +14.09% |
Feb 04, 2025 | $9.35 | $9.41 | +0.64% |
Oct 30, 2024 | $11.12 | $11.71 | +5.31% |
Aug 01, 2024 | $11.07 | $10.88 | -1.72% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Astellas Pharma Inc (ALPMF) report earnings?
Astellas Pharma Inc (ALPMF) is schdueled to report earning on Jul 30, 2025, TBA Not Confirmed.
What is Astellas Pharma Inc (ALPMF) earnings time?
Astellas Pharma Inc (ALPMF) earnings time is at Jul 30, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ALPMF EPS forecast?
ALPMF EPS forecast for the fiscal quarter 2025 (Q1) is 0.13.
---